For Research Use Only. Not for use in diagnostic procedures.

Polyclonal

IgG

Rabbit

The antibody is a rabbit polyclonal antibody raised against APP. It has been selected for its ability to recognize APP in immunohistochemical staining andwestern blotting.

Affinity Chromatography

Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3,50% glycerol.

200ug/ml (lot specific)

Store at 4 degree C for frequent use. Stored at -20 degree C to -80 degree C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Manufactured in an ISO 9001:2008 and ISO 13485:2003 Certified Laboratory.

Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customera??s specifications, please inquire.

Small volumes of anti-APP antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Immunocytochemistry (ICC), Immunohistochemistry (IHC) - Formalin/Paraffin, ELISA (EIA), Western Blot (WB)

Western blotting: 1:100-400
Immunocytochemistry in formalin fixed cells: 1:100-500
Immunohistochemistry in formalin fixed frozen section: 1:100-500
Immunohistochemistry in paraffin section: 1:50-200
Enzyme-linked Immunosorbent Assay: 1:100-200

Western Blot: Sample: Mouse Cerebrum lysate; Primary Ab: 2ug/mL Rabbit Anti-Mouse APP Antibody Second Ab: 0.2ug/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody

Western Blot: Sample: Recombinant protein.

DAB staining on fromalin fixed paraffin-embedded Kidney tissue)

a?? Da

amyloid beta (A4) precursor protein

amyloid-beta A4 protein; amyloid beta A4 protein

Amyloid-beta A4 protein

APP; AG; S-APP-alpha; S-APP-beta; Beta-CTF; Abeta42; Abeta40; Alpha-CTF; AID(59); AID(57); AID(50)??[Similar Products]

APP: a cell surface receptor that influences neurite growth, neuronal adhesion and axonogenesis. Cleaved by secretases to form a number of peptides, some of which bind to the acetyltransferase complex Fe65/TIP60 to promote transcriptional activation. The Abeta peptide is released from the cell, its extracellular deposition and accumulation form the main components of amyloid plaques in Alzheimer's disease. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis. Can promote transcription activation through binding to Fe65-Tip60 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(O) and JIP. Inhibits G(O) alpha ATPase activity. Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1. Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. Induces a RAGE-dependent pathway that activates p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1. Binds, via its C-terminus, to the PID domain of several cytoplasmic proteins, including APBB family members, the APBA family, JIP1, SHC1 and, NUMB and DAB1. Binding to DAB1 inhibits its serine phosphorylation. Associates with microtubules in the presence of ATP and in a kinesin-dependent manner. Amyloid beta-42 binds nAChRA7 in hippocampal neurons. Beta-amyloid associates with HADH2. Soluble APP binds, via its N-terminal head, to FBLN1. Expressed in all fetal tissues examined with highest levels in brain, kidney, heart and spleen. Weak expression in liver. In ***** brain, highest expression found in the frontal lobe of the cortex and in the anterior perisylvian cortex- opercular gyri. Moderate expression in the cerebellar cortex, the posterior perisylvian cortex-opercular gyri and the temporal associated cortex. Weak expression found in the striate, extra- striate and motor cortices. Expressed in cerebrospinal fluid, and plasma. 10 isoforms of the human protein are produced by alternative splicing. Isoform APP695 is the predominant form in neuronal tissue, isoform APP751 and isoform APP770 are widely expressed in non- neuronal cells. Isoform APP751 is the most abundant form in T-lymphocytes. Appican is expressed in astrocytes. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Belongs to the APP family.

Protein type: Apoptosis; Cell surface; Membrane protein, integral; Receptor, misc.; Transcription factor

Chromosomal Location of Human Ortholog: 16 C3.3|16 46.92 cM

Cellular Component: apical part of cell; axon; cell surface; ciliary rootlet; clathrin-coated pit; COPII-coated ER to Golgi transport vesicle; cytoplasm; cytoplasmic vesicle; endosome; extracellular exosome; extracellular space; Golgi apparatus; growth cone; integral component of membrane; intercellular junction; main axon; membrane; membrane raft; neuromuscular junction; neuron projection; nuclear envelope lumen; perinuclear region of cytoplasm; plasma membrane; receptor complex; rough endoplasmic reticulum; spindle midzone; terminal bouton

Molecular Function: DNA binding; enzyme binding; heparin binding; identical protein binding; metal ion binding; peptidase inhibitor activity; protease activator activity; protein binding; PTB domain binding; receptor binding; serine-type endopeptidase inhibitor activity; transition metal ion binding

Biological Process: ***** locomotory behavior; amyloid fibril formation; apoptosis; astrocyte activation; astrocyte activation during immune response; axon cargo transport; axon midline choice point recognition; axonogenesis; cell adhesion; cellular copper ion homeostasis; cellular process; cellular response to amyloid-beta; cellular response to norepinephrine stimulus; cholesterol metabolic process; collateral sprouting in the absence of injury; dendrite development; endocytosis; extracellular matrix organization; forebrain development; ionotropic glutamate receptor signaling pathway; learning; learning and/or memory; locomotory behavior; mating behavior; memory; microglia development; modulation of excitatory postsynaptic potential; mRNA polyadenylation; negative regulation of cell proliferation; negative regulation of gene expression; negative regulation of long-term synaptic potentiation; negative regulation of neuron differentiation; negative regulation of peptidase activity; nervous system development; neuromuscular process controlling balance; neuron apoptosis; neuron projection development; neuron remodeling; Notch signaling pathway; positive regulation of amyloid fibril formation; positive regulation of amyloid-beta formation; positive regulation of astrocyte activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of G2/M transition of mitotic cell cycle; positive regulation of gene expression; positive regulation of JNK cascade; positive regulation of long-term synaptic potentiation; positive regulation of microglial cell activation; positive regulation of mitotic cell cycle; positive regulation of NF-kappaB import into nucleus; positive regulation of NF-kappaB transcription factor activity; positive regulation of NIK/NF-kappaB signaling; positive regulation of peptidyl-serine phosphorylation; positive regulation of peptidyl-threonine phosphorylation; positive regulation of protein binding; positive regulation of protein metabolic process; positive regulation of protein phosphorylation; positive regulation of T cell migration; positive regulation of transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; protein amino acid phosphorylation; protein homooligomerization; regulation of epidermal growth factor receptor activity; regulation of gene expression; regulation of long-term neuronal synaptic plasticity; regulation of multicellular organism growth; regulation of protein binding; regulation of synapse structure or activity; regulation of translation; response to oxidative stress; smooth endoplasmic reticulum calcium ion homeostasis; suckling behavior; synapse organization; synaptic growth at neuromuscular junction; tumor necrosis factor production; visual learning

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.